CancerLivER: Biomarker Card

Biomarker Card: Comprehensive information about a biomarker


Biomarker ID 2218
Detailed information
CancerLivER ID2218
Biomarker MYC
Biomarker Name/Symbol (given in Publication)MYC
BiomoleculeProtein
SubjectHuman
Degree of ValidityDiagnostic or therapeutic biomarkers associated with HCC and validated on independent dataset
Experimental ConditionHCV-associated HCC v/s healthy/non-tumor/cirrhosis
Cancer typeHepatocellular carcinoma
RegulationDownregulated in HCC
Level of significance p < 0.0001
SourceTissue
PMID28947976
Type of BiomarkerDiagnostic
PathwayErbB, VEGF and MAPK signaling pathways
CohortGSE25097 dataset contain 557 samples, including 6 healthy livers, 40 cirrhotic tissue samples, 243 adjacent non-tumor samples, and 268 early-to-advanced stage HCC samples; GSE6764 dataset contains a total of 75 tissue samples, including 10 healthy liver samples, 13 cirrhosis samples, 17 dysplastic
SensitivityNA
SpecificityNA
AccuracyNA
AUCNA
DiseaseHuman HCC
Year of Publication2017
Clinical trialNO
Clinical trial (NCT Number)NA

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top